CD3 epsilon antibody [145-2C11]
GTX14351
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityMouse
TargetCd3e
Overview
- SupplierGeneTex
- Product NameCD3 epsilon antibody [145-2C11]
- Delivery Days Customer9
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID145-2c11
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- Gene ID12501
- Target nameCd3e
- Target descriptionCD3 antigen, epsilon polypeptide
- Target synonymsCD3, CD3epsilon, T3e, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain
- HostHamster
- IsotypeIgG1
- Protein IDP22646
- Protein NameT-cell surface glycoprotein CD3 epsilon chain
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC41116161




![FACS analysis of C57Bl/6 splenocytes using GTX00603-02 CD3 epsilon antibody [145-2C11] (Biotin). Solid line : Primary antibody Dashed line : Biotin Armenian hamster IgG isotype control Antibody amount : 0.125 μg](https://www.genetex.com/upload/website/prouct_img/normal/GTX00603-02/GTX00603-02_20201020_FACS_14_w_23053121_315.webp)
![FACS analysis of C57Bl/6 splenocytes using GTX00603-06 CD3 epsilon antibody [145-2C11] (FITC). Solid line : Primary antibody Dashed line : FITC Armenian hamster IgG isotype control Antibody amount : 0.5 μg](https://www.genetex.com/upload/website/prouct_img/normal/GTX00603-06/GTX00603-06_20201020_FACS_20_w_23053121_171.webp)
![FACS analysis of C57Bl/6 splenocytes using GTX00603-08 CD3 epsilon antibody [145-2C11] (PE). Solid line : Primary antibody Dashed line : PE Armenian hamster IgG isotype control Antibody amount : 1 μg](https://www.genetex.com/upload/website/prouct_img/normal/GTX00603-08/GTX00603-08_20201020_FACS_44_w_23053121_242.webp)